Elicio Therapeutics Inc.
ELTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$218.34M
Close$
$0.26
97.9% downside
Current Fair Value
97.9% downsideOvervalued by 97.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $218.34 Million |
|---|---|
| Enterprise Value | $208.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.58 |
| Beta | 1.12 |
| Outstanding Shares | 18,211,745 |
Return
| Return on Equity | 2796.45% |
|---|---|
| Return on Assets | -177.11% |
| Return on Invested Capital | -246.73% |
Valuation & Multiples
| P/E Ratio | -5.18 |
|---|---|
| PEG | -94.65 |
| Price to Sales | - |
| Price to Book Ratio | -12.53 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.46 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -3.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2152▼ 874.22% |
|---|---|
| Total Calls | 405,200▲ 1051.14% |
| Total Puts | 87,200▼ 72.34% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 17.24%▲ 4.78% |
|---|---|
| Total Invested | $28.22M▲ 70.47% |
| Investors Holding | 53▲ 13.00% |
ESG Score
No data
About Elicio Therapeutics Inc
2,021 employees